Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;101(6):1282-1286.
doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

Affiliations

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

Ayman Al Jurdi et al. Kidney Int. 2022 Jun.
No abstract available

Keywords: COVID-19; SARS-CoV-2; kidney transplant; vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Increase in anti-spike antibody levels after the third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in kidney transplant recipients (KTRs). (a,b) Total antibody (IgM, IgG, and IgA) mean fluorescence intensity (MFI) ratios to wild-type (WT) SARS-CoV-2 antigens before and after the third vaccine dose in KTRs (n = 51; a) and in prepandemic healthy controls (HCs; n = 5) and prepandemic kidney transplant control patients (KCs; n = 15), measured by Luminex-based multiplex assay (b). (c,d) Antibody MFI ratios for anti-spike antibodies of WT and variants of SARS-CoV-2 before and after the third vaccine dose in KTRs (c) and prepandemic HCs and KCs (d). Horizontal lines indicate positivity threshold for assay. (e,f) Proportion of KTRs with anti-spike antibodies against WT and variants of SARS-CoV-2 before (e) and after (f) the third vaccine dose. (a,c) Statistic by Wilcoxon matched-pairs signed rank test. (e,f) Statistic by χ2 test. NC, nucleocapsid; RBD, receptor-binding domain.
Figure 2
Figure 2
Poor anti–receptor binding domain (RBD) antibody and neutralization responses to the Omicron variant before and after the third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in kidney transplant recipients (KTRs). (a,b) Anti–SARS-CoV-2 RBD IgG antibody OD 450 values to wild-type (WT), Delta (B.1.617.2), and Omicron (B.1.1.529) variants of SARS-CoV-2 before and after the third vaccine dose in KTRs (n = 51; a) and in prepandemic healthy controls (HCs; n = 5) and prepandemic kidney transplant control patients (KCs; n = 15), measured by enzyme-linked immunosorbent assay (b). (c,d) Percentage of neutralization to WT, Delta, and Omicron variants of SARS-CoV-2 before and after the third vaccine dose in KTRs (n = 51; c) and in prepandemic HCs (n = 5) and KCs (n = 15), measured by surrogate virus neutralization test (d). Horizontal lines indicate positivity threshold for assay. (e) Proportion of KTRs with a positive neutralization response before and after the third vaccine dose in KTRs. (a,c) Statistic by Friedman test with Dunn correction for multiple comparisons. (e) Statistic by χ2 test.

References

    1. World Health Organization WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/
    1. CDC: variant proportions. https://covid.cdc.gov/covid-data-tracker/#variant-proportions
    1. Caillard S., Chavarot N., Francois H., et al. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21:1295–1303. - PMC - PubMed
    1. Boyarsky B.J., Werbel W.A., Avery R.K., et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed
    1. Benotmane I., Gautier-Vargas G., Cognard N., et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99:1498–1500. - PMC - PubMed

Publication types

Supplementary concepts